Gilead Sciences News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

29.07.22	Gilead's Biktarvy Shows High Efficacy For Broad Range Of People Initiating Treatment For HIV (RTTNews)
22.07.22	Kite's CAR T-cell Therapy Tecartus Gets Positive CHMP Opinion In Acute Lymphoblastic Leukemia (RTTNews)
22.07.22	Gilead Sciences: CHMP Recommends Full Marketing Authorization For Veklury To Treat COVID-19 (RTTNews)
19.07.22	Gilead Renews Deal With EC To Procure Remdesivir For Member States In EU, EEA (RTTNews)
28.06.22	Gilead: Kite's CAR T-cell Therapy Yescarta Gets EU Approval To Treat Relapsed Or Refractory FL (RTTNews)
24.06.22	Gilead: CHMP Adopts Positive Opinion For Lenacapavir To Treat People With Multi-Drug Resistant HIV (RTTNews)
23.06.22	Gilead: Week 48 Findings Underscore Efficacy Of Bulevirtide For Treatment Of Chronic HDV (RTTNews)
06.06.22	Gilead: Trodelvy Extends Overall Survival In Second-Line Metastatic TNBC - Quick Facts (RTTNews)
04.06.22	Everest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients (PR Newswire)
17.05.22	FDA Lifts Clinical Hold On Gilead's Investigational Lenacapavir For Treatment & Prevention Of HIV (RTTNews)
05.05.22	Form S-8 882095 (RSS)
28.04.22	Gilead Sciences Inc. Q1 Profit Increases, beats estimates (RTTNews)
26.04.22	FDA Approves Gilead's Remdesivir To Treat Young Children With COVID-19 (RTTNews)
25.04.22	Gilead Science Says Several Studies Confirm Remdesivir Activity In Treating COVID-19 (RTTNews)
13.04.22	Form 4 882095 (RSS)
11.04.22	FDA Lifts Partial Clinical Hold On Gilead Sciences' MDS And AML Magrolimab Studies (RTTNews)
11.04.22	Notice of exempt solicitation submitted by non-management (RSS)
24.03.22	Form DEF 14A 882095 (RSS)
14.03.22	Form 4 882095 (RSS)
07.03.22	Gilead: Phase 3 TROPiCS-02 Study Meets Primary Endpoint (RTTNews)
03.03.22	Form 4 882095 (RSS)
01.03.22	Gilead Sciences Gets CRL From FDA For Investigational Lenacapavir Due To Vial Compatability Issues (RTTNews)
11.02.22	Gilead: Laboratory Results Show Veklury Remains Active Against All Major SARS-CoV-2 Variants (RTTNews)
10.02.22	Form SC 13G/A 882095 (RSS)
08.02.22	Form 4 882095 (RSS)
02.02.22	Confidential treatment order (RSS)
02.02.22	GlaxoSmithKline Says Gilead, ViiV Healthcare Settle Patent Dispute Over HIV Drug (RTTNews)
01.02.22	Gilead Sciences FY22 Outlook Below Street View (RTTNews)
01.02.22	Gilead Sciences Inc. Q4 Profit Decreases, misses estimates (RTTNews)
01.02.22	Form 8-K 882095 (RSS)
31.01.22	Gilead : FDA Okays New Label Update For CAR T-Cell Therapy Yescarta (RTTNews)
28.01.22	Form 4 882095 (RSS)
26.01.22	Gilead: FDA Places Partial Clinical Hold On Studies Evaluating Magrolimab - Azacitidine Combination (RTTNews)
25.01.22	Biotech Stocks Facing FDA Decision In February 2022 (RTTNews)
24.01.22	FDA Expands EUA Of Veklury For Non-hospitalized Adults, Pediatric Patients With COVID-19 (RTTNews)
10.01.22	Gilead Announces Clinical Trial Collaborations With Merck - Quick Facts (RTTNews)
03.01.22	Form 4 882095 (RSS)
23.12.21	Top 10 Blockbuster Drugs In 2021 (RTTNews)
23.12.21	Gilead' Veklury Reduces Risk Of Hospitalization In High-risk Patients With COVID-19 In Phase 3 Study (RTTNews)
22.12.21	Gilead: FDA Places Clinical Hold On Studies Of Injectable Lenacapavir For HIV Treatment & Prevention (RTTNews)
21.12.21	Gilead Sciences: EC Approves Variation To Conditional Marketing Authorization For Veklury (RTTNews)
14.12.21	Merck's HIV Trials Put On Clinical Hold, Vifor Gets A Suitor, VERU Scores FDA Nod... (RTTNews)
11.12.21	Kite : Yescarta Quadruples Median Event-Free Survival Duration In Refractory Large B-Cell Lymphoma (RTTNews)
09.12.21	Form 4 882095 (RSS)
23.11.21	Gilead Sciences: European Commission Grants Marketing Authorization For Trodelvy (RTTNews)
19.11.21	Gilead Files BLA For Bulevirtide To Treat Chronic HDV Infection (RTTNews)
13.11.21	S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2021 Review Results (PR Newswire)
11.11.21	Gilead : Phase 2b Study Of Sacituzumab Govitecan On Aggressive Type Of Breast Cancer Meets Main Goal (RTTNews)
29.10.21	Gilead Sciences : Study Data Of Biktarvy In People Living With HIV Show High Effectiveness (RTTNews)
29.10.21	Gilead Sciences Lifts FY21 Outlook (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester